1311P Phase II, open-label study of frontline tusamitamab ravtansine with pembrolizumab ± chemotherapy in advanced non-squamous non-small cell lung cancer: Updated results from CARMEN-LC05 trial
| Autor: | Rodriguez Abreu, D., Veillon, R., Ravoire, M., Gonzalez-Larriba, J.L., Orlandi, F.J., Nagy, T., Paz-Ares, L.G., Huang, C.H., Roubec, J., Isambert, N., García Campelo, M.R., Matias, D.D.A., Ray, F., Celedon, P., Onn, A., Shamai, S., Carcereny, E., Charbonnier, L., Soufflet, C., Esteban González, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S834-S834 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|